Page last updated: 2024-10-24

calmidazolium and Cancer of Pituitary

calmidazolium has been researched along with Cancer of Pituitary in 3 studies

calmidazolium: powerful inhibitor of or red blood cell Ca++-ATPase & Ca++ transport into inside-out red blood cell vesicles; RN refers to chloride; structure in first source; an antagonist of calmodulin
calmidazolium : An imidazolium ion that is imidazolium cation substituted by a bis(4-chlorophenyl)methyl group at position 1 and a 2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl group at position 3. It acts as an antagonist of calmodulin, a calcium binding messenger protein.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Newton, CJ1
Eycott, K1
Green, V1
Atkin, SL1
Wolfe, SE1
Brostrom, CO1
Brostrom, MA1
White, BA1

Other Studies

3 other studies available for calmidazolium and Cancer of Pituitary

ArticleYear
Response of estrogen receptor containing tumour cells to pure antiestrogens and the calmodulin inhibitor, calmidzolium chloride.
    The Journal of steroid biochemistry and molecular biology, 2000, Volume: 73, Issue:1-2

    Topics: Breast Neoplasms; Calmodulin; Cell Death; Dose-Response Relationship, Drug; Drug Synergism; Estradio

2000
Mechanisms of action of inhibitors of prolactin secretion in GH3 pituitary cells. I. Ca2+-dependent inhibition of amino acid incorporation.
    Molecular pharmacology, 1986, Volume: 29, Issue:4

    Topics: Acetylcholine; Amino Acids; Animals; Bromocriptine; Calcium; Carbachol; Cell Line; Chlorpromazine; I

1986
Evidence for a role of calmodulin in the regulation of prolactin gene expression.
    The Journal of biological chemistry, 1985, Jan-25, Volume: 260, Issue:2

    Topics: Animals; Calcium; Calmodulin; Cell Line; Epidermal Growth Factor; Gene Expression Regulation; Imidaz

1985